Literature DB >> 33800040

Comparison of Enterococcus faecalis Biofilm Removal Efficiency among Bacteriophage PBEF129, Its Endolysin, and Cefotaxime.

Hyun Keun Oh1, Yoon Jung Hwang1, Hye Won Hong2, Heejoon Myung1,2,3.   

Abstract

Enterococcus faecalis is a Gram-positive pathogen which colonizes human intestinal surfaces, forming biofilms, and demonstrates a high resistance to many antibiotics. Especially, antibiotics are less effective for eradicating biofilms and better alternatives are needed. In this study, we have isolated and characterized a bacteriophage, PBEF129, infecting E. faecalis. PBEF129 infected a variety of strains of E. faecalis, including those exhibiting antibiotic resistance. Its genome is a linear double-stranded DNA, 144,230 base pairs in length. Its GC content is 35.9%. The closest genomic DNA sequence was found in Enterococcus phage vB_EfaM_Ef2.3, with a sequence identity of 99.06% over 95% query coverage. Furthermore, 75 open reading frames (ORFs) were functionally annotated and five tRNA-encoding genes were found. ORF 6 was annotated as a phage endolysin having an L-acetylmuramoyl-l-alanine amidase activity. We purified the enzyme as a recombinant protein and confirmed its enzymatic activity. The endolysin's host range was observed to be wider than its parent phage PBEF129. When applied to bacterial biofilm on the surface of in vitro cultured human intestinal cells, it demonstrated a removal efficacy of the same degree as cefotaxime, but much lower than its parent bacteriophage.

Entities:  

Keywords:  Enterococcus faecalis; antibiotic; biofilm; endolysin; phage

Year:  2021        PMID: 33800040      PMCID: PMC7999683          DOI: 10.3390/v13030426

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  54 in total

1.  The endolysin from the Enterococcus faecalis bacteriophage VD13 and conditions stimulating its lytic activity.

Authors:  Steven M Swift; D Treva Rowley; Carly Young; Ashley Franks; Paul Hyman; David M Donovan
Journal:  FEMS Microbiol Lett       Date:  2016-10-01       Impact factor: 2.742

Review 2.  Antibiotic resistance of bacterial biofilms.

Authors:  Niels Høiby; Thomas Bjarnsholt; Michael Givskov; Søren Molin; Oana Ciofu
Journal:  Int J Antimicrob Agents       Date:  2010-02-10       Impact factor: 5.283

Review 3.  A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis.

Authors:  Maya Beganovic; Megan K Luther; Louis B Rice; Cesar A Arias; Michael J Rybak; Kerry L LaPlante
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

Review 4.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

5.  tRNAscan-SE On-line: integrating search and context for analysis of transfer RNA genes.

Authors:  Todd M Lowe; Patricia P Chan
Journal:  Nucleic Acids Res       Date:  2016-05-12       Impact factor: 16.971

6.  Synergistic Removal of Static and Dynamic Staphylococcus aureus Biofilms by Combined Treatment with a Bacteriophage Endolysin and a Polysaccharide Depolymerase.

Authors:  Nanna M C Olsen; Elowine Thiran; Tobias Hasler; Thomas Vanzieleghem; Georgios N Belibasakis; Jacques Mahillon; Martin J Loessner; Mathias Schmelcher
Journal:  Viruses       Date:  2018-08-18       Impact factor: 5.048

Review 7.  Antibiotics versus biofilm: an emerging battleground in microbial communities.

Authors:  Divakar Sharma; Lama Misba; Asad U Khan
Journal:  Antimicrob Resist Infect Control       Date:  2019-05-16       Impact factor: 4.887

Review 8.  Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention.

Authors:  Zohra Khatoon; Christopher D McTiernan; Erik J Suuronen; Thien-Fah Mah; Emilio I Alarcon
Journal:  Heliyon       Date:  2018-12-28

9.  Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease.

Authors:  Yi Duan; Cristina Llorente; Sonja Lang; Katharina Brandl; Huikuan Chu; Lu Jiang; Richard C White; Thomas H Clarke; Kevin Nguyen; Manolito Torralba; Yan Shao; Jinyuan Liu; Adriana Hernandez-Morales; Lauren Lessor; Imran R Rahman; Yukiko Miyamoto; Melissa Ly; Bei Gao; Weizhong Sun; Roman Kiesel; Felix Hutmacher; Suhan Lee; Meritxell Ventura-Cots; Francisco Bosques-Padilla; Elizabeth C Verna; Juan G Abraldes; Robert S Brown; Victor Vargas; Jose Altamirano; Juan Caballería; Debbie L Shawcross; Samuel B Ho; Alexandre Louvet; Michael R Lucey; Philippe Mathurin; Guadalupe Garcia-Tsao; Ramon Bataller; Xin M Tu; Lars Eckmann; Wilfred A van der Donk; Ry Young; Trevor D Lawley; Peter Stärkel; David Pride; Derrick E Fouts; Bernd Schnabl
Journal:  Nature       Date:  2019-11-13       Impact factor: 49.962

Review 10.  Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?

Authors:  Stephen T Abedon
Journal:  Antibiotics (Basel)       Date:  2019-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.